I'm going to switch a little bit here to drug prices and negotiations, something that I don't think gets a lot of attention.
Given the diverse workforce you represent, and the issue over drug pricing and benefits, how do you think this will affect negotiations across this country, be it the public or the private sector, if drug prices are going to...and patents are going to be extended with regard to that?